维普期刊资源整合服务平台（V6.5）

128篇 您的检索式：作者名="Pengo"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	A consensus docu- ment of the Italian Federation of Thrombosis Cen- ters (FCSA) 显示文摘	Pengo V Crippa L FaIanga A et aL Questions and answers on the use of dahigatran and perspec- tives on the use of other new oral anticoagulants in patients with atrial fibrillation	2011	Thromb Haemost2011，106，5：	1
2	Argatrobanin the management ofheparin-induced thrombocytopenia 显示文摘	Babuin L Pengo V	2010	Vase Health RiskManag2010，7，6：	1
3	Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance显示文摘	SCORDO M G PENGO V SPINA E	2002	Chin Pharmacol Ther2002，72，6：	1
4	Clinical course of high-risk patients diagnosed with antiphospholipid syndrome显示文摘	Pengo V Ruffatti A Legnani C	2010	J Thromb Haemost2010，8，：	1
5	Incidence of a firstthromboembolic event in carriers of isolated lupus anticoagulant 显示文摘	PENGO V TESTA S MAHTINELLI I	2015	Thromb Res2015，135，：	1
6	A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants 显示文摘	Pengo V Biasiolo A Pegoraro C	2004	Thromb Haemost2004，2，5：	1
7	lie association betweencirculating antibodies against domain I of beta2- glycoprotein I andthrombosis : an international multicenter study 显示文摘	DE LAAT B PENGO V PABINGER I	2009	J Thromb Haemost2009，7，：	1
8	The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs显示文摘	Cosmi B Legnani C Pengo V	2013	Thromb Haemost2013，109，3：	1
9	Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism显示文摘	Pengo V Lensing AW Prins MH	2004	N Eng J Med2004，350，22：	1
10	VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study显示文摘	Zambon CF Pengo V Padrini R	2011	Pharmacogenomics2011，12，1：	1
11	Incidence of chronicthromboembolicpulmonary hypertension after pulmonaryembolism显示文摘	Pengo V* Lensing AW Prins MH	2004	N Engl J Med2004，350，22：	1
12	Antiphospholipid syn-drome :antibodies to Domain 1 of p2- glycoprotein 1 correctly classifypatients at risk显示文摘	PENGO V RUFFATTI A TONELLO M	2015	J Thromb Haemost2015，13，：	1
13	Diagnosis and therapyof antiphospholipid syndrome 显示文摘	PENGO V DENAS G PADAYATOL SJ	2015	Pol Arch Med Wewn2015，125，：	1
14	Synthesis, characteriz- ation and properties of water-soluble gold nanoparticles with tunable core size显示文摘	Pengo P Polizzi S Battagliarin M	2003	J Mater Chem2003，13，10：	1
15	Incidence of chronic thro~hc pulmonary hypertension after pulmonary embolism 显示文摘	Pengo V Lerrsing AW Prns MH	2004	N Engl J Med2004，350，22：	1
16	Update of the guidelines for lu- pus anticoagulant detection显示文摘	Pengo V Tripodi A Reber G	2009	J Thromb Haemost2009，7，10：	1
17	New trends in anticoagulant therapy显示文摘	Pengo V Pegoraro C Iliceto S	2004	Is Med Assoc J2004，6，8：	1
18	From acute pulmonary embolism to chronic thrombus embolic pulmonary hypertension 显示文摘	Pengo V Prandoni P	2005	Ital Heart J2005，21，6：	1
19	The reduction of rare earth oxides to metal and their subsequent rolling显示文摘	PENGO R FAVARON P MANENTE G	1991	Nuclear Instruments and Methods in Physics Research A1991，303，：	1
20	FSH receptor gene polymorphisms in fertile and infertile Italian men 显示文摘	Pengo M Ferlin A Arredi B	2006	Reprod Biomed Online2006，13，6：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示